PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.51%
Revenue growth under 50% of ADI's 14.73%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.75%
Gross profit growth under 50% of ADI's 24.98%. Michael Burry would be concerned about a severe competitive disadvantage.
2.63%
EBIT growth below 50% of ADI's 268.42%. Michael Burry would suspect deeper competitive or cost structure issues.
2.40%
Operating income growth under 50% of ADI's 268.42%. Michael Burry would be concerned about deeper cost or sales issues.
2.95%
Net income growth under 50% of ADI's 270.05%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.03%
EPS growth under 50% of ADI's 231.25%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.96%
Diluted EPS growth under 50% of ADI's 231.25%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.11%
Share reduction while ADI is at 8.68%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.21%
Reduced diluted shares while ADI is at 8.68%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.20%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
-9.04%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
58.23%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
94.62%
10Y revenue/share CAGR at 50-75% of ADI's 134.81%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
55.90%
5Y revenue/share CAGR similar to ADI's 60.29%. Walter Schloss might see both companies benefiting from the same mid-term trends.
38.84%
3Y revenue/share CAGR above 1.5x ADI's 22.26%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
491.32%
10Y OCF/share CAGR above 1.5x ADI's 126.00%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
191.60%
5Y OCF/share CAGR above 1.5x ADI's 60.08%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
97.03%
3Y OCF/share CAGR above 1.5x ADI's 61.69%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
928.53%
Net income/share CAGR above 1.5x ADI's 13.91% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
138.70%
Positive 5Y CAGR while ADI is negative. John Neff might view this as a strong mid-term relative advantage.
83.99%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
56.79%
Below 50% of ADI's 452.19%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.46%
Below 50% of ADI's 314.61%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
67.39%
3Y equity/share CAGR at 50-75% of ADI's 126.75%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
575.06%
10Y dividend/share CAGR above 1.5x ADI's 176.26%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
129.88%
5Y dividend/share CAGR above 1.5x ADI's 64.38%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
49.37%
3Y dividend/share CAGR 1.25-1.5x ADI's 43.23%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
5.53%
AR growth is negative/stable vs. ADI's 12.19%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
7.85%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.43%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.24%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
-5.65%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
0.51%
R&D dropping or stable vs. ADI's 6.93%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
4.46%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.